Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sexual Dysfunction, Physiological 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Anxiety Disorders 1

Interventions

Therapeutics 9Psychiatric Rehabilitation 9Music Therapy 8Cognitive Behavioral Therapy 7Mindfulness 6Surveys and Questionnaires 5Counseling 5Acupuncture Therapy 5Standard of Care 4Mindfulness-Based Stress Reduction 4Methods 4Imagery, Psychotherapy 4Early Intervention, Educational 4Autogenic Training 4Art Therapy 4Therapeutic Touch 3Psychosocial Intervention 3Psilocybin 3Mindfulness-Based Cognitive Therapy 3Massage 3Hypnosis 3Exercise 3Control Groups 3Aromatherapy 3Acceptance and Commitment Therapy 3Yoga 2Touch 2Observation 2Niacin 2Gabapentin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anxiety Disorders × Dehydroepiandrosterone × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡